abrdn plc Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)
abrdn plc cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,817 shares of the medical research company’s stock after selling 1,027 shares during the quarter. abrdn plc’s […]
abrdn plc cut its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,817 shares of the medical research company’s stock after selling 1,027 shares during the quarter. abrdn plc’s […]
